Balaji Kirushnan: Advancing Regional Citrate Anticoagulation in CRRT – From Experience to Implementation
Balaji Kirushnan, Senior Consultant Nephrologist, UK at Kauvery Hospital, Senior Registrar at Apollo Hospitals, shared a post on LinkedIn:
“Advancing Regional Citrate Anticoagulation in CRRT — from experience to implementation.
It was a privilege to be part of the Vantive Advisory Board on Citrate Anticoagulation, held in Hyderabad, focusing on ‘Regional Citrate Anticoagulation in CRRT – 37 years of evolution and the road ahead for India.’
The meeting brought together experienced clinicians and experts to discuss an important question: How do we move beyond the established evidence and experience with RCA to develop robust, practical and sustainable RCA programs across India?
The discussions touched upon several aspects of implementing RCA in real-world practice — protocol development, monitoring, safety, troubleshooting, training and standardisation — while also recognising the diversity of clinical settings across the country.
What made the meeting particularly valuable was the opportunity to exchange experiences, understand the challenges faced at different centres and explore practical ways of making RCA more accessible and reproducible.
A special thanks to Dr. Rajasekara Chakravarthi, chairperson, and to the distinguished experts Prof. Ravindra Mehta, Prof. Ashita Tolwani and Dr. Manish Kaushik for their insights and engaging discussions.
The journey of RCA has evolved considerably over the past 37 years. The next step is to translate that experience into structured, safe and scalable practice in India.
Looking forward to contributing to this exciting journey of advancing CRRT and extracorporeal support in India.”
Stay updated with Hemostasis Today.
-
Nov 8, 2026, 19:31Anna Kajaste-Rudnitski: Presenting AAV-Induced p53 Signalling in Human CNS Cells at ESGCT 26
-
Nov 8, 2026, 19:29David McIntosh: Cybersecurity Matters, but Blood Availability Remains the Bigger Challenge
-
Nov 8, 2026, 19:26Wenxue Ma: An Integrative Framework for Macrophage-Mediated Therapeutic Resistance in Cancer
-
Nov 8, 2026, 19:25Yildiz Yigit: Presenting a Polycythemia Vera Case at the MPN Subcommittee Session
-
Nov 8, 2026, 18:56Denis Oduor: Strengthening the Regulation and Delivery of Blood Transfusion and Transplantation Services
-
Nov 8, 2026, 18:28Raghavendra Rao: A Narrative Review on Chronic Venous Disease during Pregnancy
-
Nov 8, 2026, 17:57Dhiren Patel: PLD1-Derived Phospholipids Regulate NAD Kinase and ROS Production in Neutrophils
-
Nov 8, 2026, 17:48Andra T.: What Causes Antiphospholipid Syndrome? – Four Steps, not One Cause
-
Nov 8, 2026, 17:38Nasrin Samadi: Can a Normal Clotting Test Be Misleading?